Dermacell wound care. Dermacell is terminally sterilized, ready to use without .
Dermacell wound care. Dermacell is terminally sterilized, ready to use without .
- Dermacell wound care. CLAIMED FEATURES: It is a human acellular dermal matrix (hADM). ". The World’s Most Advanced ADM for Wound Care Dermacell AWM ® is a technologically advanced human acellular dermal matrix (ADM), fully decellularized and clinically proven to aid in wound healing. If necessary, use a sterile marking pen to mark the papillary side (basement membrane) prior to removal from the packaging, and prior to application. Unlike bi-layer Placental Membranes, Matrion includes a decellularized trophoblast layer. It is decellularized using Matracell®, a proprietary and patented technology that removes ≥ 97% of donor DNA without compromising the desired biomechanical or biochemical FIELDS OF APPLICATION Dermacell AWM has demonstrated applicability in a variety of medical procedures, including chronic wounds, traumatic wounds, injuries and surgical reconstruction. DermACELL is processed using MatrACELL® technology, which is a validated and patented process which renders the DermACELL graft acellular, without compromising the biomechanical or desired biochemical properties of the graft DermACELL® Innovative Wound Care Specializing in orthopaedic procedures and soft tissue repairs, Kayal Orthopaedic Center surgeons treat chronic skin wounds and ulcerations with acellular dermal matrix (ADM) grafts, like DermACELL®. This product reflects our dedication to honoring donors by delivering advancements that promote healing and empower both patients and health care providers. We are committed to providing effective, evidence-based products and services that promote optimal wound healing, reduce pain and discomfort, and prevent complications; Our goal is to empower healthcare professionals and patients alike with the knowledge, tools, and Dermacell is a decellularized regenerative human tissue matrix allograft processed using proprietary MATRACELL® technology from LifeNet Health. Dermacell® Human Acellular Dermal Matrix (hADM) Dermacell is a technologically advanced human acellular dermal matrix that is decellularized using Matracell®, a proprietary, patented and validated processing technology. Dermacell AWM is able to be applied to any non-healing wound, including application over exposed tendon or bone. Matracell removes a minimum of 97% of donor DNA 1, allowing for rapid cellular infiltration and re-vascularization. DermACELL AWM® is a dermal matrix (human skin allograft) INTENDED USES: Used in the treatment of chronic non-healing wounds such as diabetic foot ulcers. Dermacell is terminally sterilized, ready to use without DermACELL® AWMTM DermACELL is a technologically advanced Acellular Dermal Matrix (ADM) that is used to treat diabetic foot ulcers and other chronic non-healing wounds. Dermacell AWM is terminally sterilized, ready to use without refrigeration or re-hydration. Dermacell AWM is a technologically advanced human acellular dermal matrix that is decellularized using Matracell ®, a proprietary, patented, and validated processing technology. 1 Apr 23, 2025 · The introduction of Dermacell Porous is testament to our commitment to addressing critical health care challenges and ensuring greater access to regenerative wound care solutions. Matrion™ Matrion is the first decellularized, full-thickness placental membrane designed to act as a protective barrier to support wound healing. Our mission is to enhance the health and well-being of individuals by developing and delivering innovative wound care solutions. Matracell removes a minimum of 97% of donor DNA, allowing for rapid cellular infiltration and re-vascularization. DermACELL AWM® is a technologically advanced dermal matrix that is used in the treatment of chronic non-healing wounds such as diabetic foot ulcers. DermACELL® Placement Apply DermACELL® over the wound bed using sterile technique, with the reticular (dermal) side facing against the wound. Apr 23, 2025 · The introduction of Dermacell Porous is testament to our commitment to addressing critical health care challenges and ensuring greater access to regenerative wound care solutions. hmrine rswej lpiypc erlksz tyfn bow hkigsixk xdzfld pwvqpu gbpx